Experienced in Transient Ischemic Attack (TIA)

Ratika Parkash

Halifax, NS, CA 
Clinical Trials:Currently Recruiting for 1 Trial
Experienced in Transient Ischemic Attack (TIA)
Halifax, NS, CA 
OverviewLocationsClinical Research

Overview

Ratika Parkash practices in Halifax, Canada. Parkash is rated as an Experienced expert by MediFind in the treatment of Transient Ischemic Attack (TIA). Their top areas of expertise are Atrial Fibrillation, Arrhythmias, Ventricular Tachycardia, Cardiac Ablation, and Pacemaker Implantation.

Their clinical research consists of co-authoring 162 peer reviewed articles and participating in 9 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 3 articles in the study of Transient Ischemic Attack (TIA).

Locations

Halifax, NS, Canada
Other Locations
London, ON, Canada
Halifax, Canada
Victoria, BC, Canada
Dartmouth, NS, Canada
Vancouver, BC, Canada
Sherbrooke, QC, Canada

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

9 Clinical Trials

Reversal of Atrial Substrate to Prevent Atrial Fibrillation
Reversal of Atrial Substrate to Prevent Atrial Fibrillation
Enrollment Status: Recruiting
Publish Date: December 18, 2024
Intervention Type: Other
Study Phase: Not Applicable
The Optimal Anticoagulation for Enhanced Risk Patients Post-Catheter Ablation for Atrial Fibrillation Trial
The Optimal Anticoagulation for Enhanced Risk Patients Post-Catheter Ablation for Atrial Fibrillation Trial
Enrollment Status: Completed
Publish Date: October 06, 2025
Intervention Type: Drug
Study Drugs: Rivaroxaban, Acetylsalicylic acid
Study Phase: Phase 4
Resynchronization/Defibrillation for Ambulatory Heart Failure Trial in Patients With Permanent Atrial Fibrillation
Resynchronization/Defibrillation for Ambulatory Heart Failure Trial in Patients With Permanent Atrial Fibrillation
Enrollment Status: Active_not_recruiting
Publish Date: May 10, 2024
Intervention Type: Device
Study Phase: Not Applicable
Assessment of Midodrine in the Prevention of Vasovagal Syncope: The Prevention of Syncope Trial IV (Post 4)
Assessment of Midodrine in the Prevention of Vasovagal Syncope: The Prevention of Syncope Trial IV (Post 4)
Enrollment Status: Active_not_recruiting
Publish Date: May 09, 2024
Intervention Type: Drug
Study Drug: Midodrine Hydrochloride
Study Phase: Phase 4
AUGMENTED WIDE AREA CIRCUMFERENTIAL CATHETER ABLATION FOR REDUCTION OF ATRIAL FIBRILLATION RECURRENCE - A RANDOMIZED CLINICAL TRIAL (The AWARE Trial)
AUGMENTED WIDE AREA CIRCUMFERENTIAL CATHETER ABLATION FOR REDUCTION OF ATRIAL FIBRILLATION RECURRENCE - A RANDOMIZED CLINICAL TRIAL (The AWARE Trial)
Enrollment Status: Active_not_recruiting
Publish Date: January 31, 2024
Intervention Type: Procedure
Study Phase: Not Applicable
A Randomized Ablation-based Atrial Fibrillation Rhythm Control Versus Rate Control Trial in Patients With Heart Failure and High Burden Atrial Fibrillation
A Randomized Ablation-based Atrial Fibrillation Rhythm Control Versus Rate Control Trial in Patients With Heart Failure and High Burden Atrial Fibrillation
Enrollment Status: Completed
Publish Date: October 21, 2021
Intervention Type: Other, Procedure
Study Phase: Not Applicable
Integrated Management Program Advancing Community Treatment of Atrial Fibrillation (IMPACT-AF)
Integrated Management Program Advancing Community Treatment of Atrial Fibrillation (IMPACT-AF)
Enrollment Status: Completed
Publish Date: March 09, 2021
Intervention Type: Other
Study Phase: Not Applicable
Computer Simulated Atrial Fibrillation Tool to Reduce Hospitalizations and Emergency Department Visits
Computer Simulated Atrial Fibrillation Tool to Reduce Hospitalizations and Emergency Department Visits
Enrollment Status: Completed
Publish Date: July 22, 2020
Intervention Type: Device, Other
Study Phase: Not Applicable
Reversal of Atrial Substrate to Prevent Atrial Fibrillation - A Pilot Study
Reversal of Atrial Substrate to Prevent Atrial Fibrillation - A Pilot Study
Enrollment Status: Completed
Publish Date: December 18, 2019
Intervention Type: Other, Behavioral
Study Phase: Not Applicable
View 8 Less Clinical Trials

162 Total Publications

Rural-Urban Disparities in the Management and Outcomes of Atrial Fibrillation in Emergency Departments in Canada.
Rural-Urban Disparities in the Management and Outcomes of Atrial Fibrillation in Emergency Departments in Canada.
Journal: Circulation. Cardiovascular quality and outcomes
Published: October 15, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Parkash's expertise for a condition
ConditionClose
    View All 10 Advanced Conditions
    View All 13 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile